Does MEGLUMINE Cause Obesity? 236 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 236 reports of Obesity have been filed in association with MEGLUMINE. This represents 40.3% of all adverse event reports for MEGLUMINE.
236
Reports of Obesity with MEGLUMINE
40.3%
of all MEGLUMINE reports
236
Deaths
228
Hospitalizations
How Dangerous Is Obesity From MEGLUMINE?
Of the 236 reports, 236 (100.0%) resulted in death, 228 (96.6%) required hospitalization, and 233 (98.7%) were considered life-threatening.
Is Obesity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGLUMINE. However, 236 reports have been filed with the FAERS database.
What Other Side Effects Does MEGLUMINE Cause?
Off label use (389)
Maternal exposure during pregnancy (300)
Joint swelling (294)
Pemphigus (289)
Glossodynia (288)
Inflammation (285)
Pain (284)
General physical health deterioration (283)
Folliculitis (282)
Hypertension (282)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
TOCILIZUMAB (1,630)
ABATACEPT (1,605)
INFLIXIMAB (1,536)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
Which MEGLUMINE Alternatives Have Lower Obesity Risk?
MEGLUMINE vs MELATONIN
MEGLUMINE vs MELOXICAM
MEGLUMINE vs MELPERONE
MEGLUMINE vs MELPHALAN
MEGLUMINE vs MEMANTINE